Related references
Note: Only part of the references are listed.Immunomodulators: use in combined therapy against leishmaniasis
Jane E. Dalton et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2010)
CpG oligodeoxynucleotide augments the antileishmanial activity of miltefosine against experimental visceral leishmaniasis
Shraddha A. Sane et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Combination therapy for visceral leishmaniasis
Johan van Griensven et al.
LANCET INFECTIOUS DISEASES (2010)
Pharmacology and Chemistry of a Potent Hepatoprotective Compound Picroliv Isolated from the Roots and Rhizomes of Picrorhiza kurroa Royle ex Benth. (Kutki)
Praveen C. Verma et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2009)
Synthesis of marine alkaloid: 8,9-dihydrocoscinamide B and its analogues as Novel class of antileishmanial agents
Leena Gupta et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Comparative study of the efficacy of formulations containing fluconazole or paromomycin for topical treatment of infections by Leishmania (Leishmania) major and Leishmania (Leishmania) amazonensis
Samuel Vidal Mussi et al.
PARASITOLOGY RESEARCH (2007)
In vitro and in vivo interactions between miltefosine and other antileishmanial drugs
K Seifert et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Use of Leishmania donovani field isolates expressing the luciferase reporter gene in in vitro drug screening
Ashutosh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Efficacy of picroliv in combination with miltefosine, an orally effective antileishmanial drug against experimental visceral leishmaniasis
S Gupta et al.
ACTA TROPICA (2005)
Ascorbate-mediated enhancement of reactive oxygen species generation from polymorphonuclear leukocytes: modulatory effect of nitric oxide
P Sharma et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Prophylactic potential of autoclaved Leishmania donovani with BCG against experimental visceral leishmaniasis
JK Srivastava et al.
PARASITOLOGY (2003)
Flow cytometry study of polymorphonuclear neutrophil oxidative burst: a comparison of three fluorescent probes
S Walrand et al.
CLINICA CHIMICA ACTA (2003)
Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major
AA Alrajhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Chemotherapy of leishmaniasis
SL Croft et al.
CURRENT PHARMACEUTICAL DESIGN (2002)
Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator
I Arevalo et al.
CLINICAL INFECTIOUS DISEASES (2001)
Share Paper
